Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
ECOR Stock Summary
Top 10 Correlated ETFs
ECOR
In the News
electroCore, Inc. (ECOR) Q4 2023 Earnings Call Transcript
electroCore, Inc. (ECOR) Q4 2023 Earnings Call Transcript
ElectroCore, Inc. (ECOR) Reports Q4 Loss, Lags Revenue Estimates
ElectroCore, Inc. (ECOR) came out with a quarterly loss of $0.61 per share versus the Zacks Consensus Estimate of a loss of $0.55. This compares to loss of $1.22 per share a year ago.
electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2023 Financial Results on Wednesday, March 13, 2024
ROCKAWAY, N.J., March 05, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial results for the fourth quarter and year ended December 31, 2023, after the close of the market on Wednesday, March 13, 2024. Management will host a conference call and webcast at 4:30 PM EST to discuss the financial results and answer questions.
electroCore, Inc. (ECOR) Q3 2023 Earnings Call Transcript
electroCore, Inc. (NASDAQ:ECOR ) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Dan Goldberger – Chief Executive Officer Brian Posner – Chief Financial Officer Conference Call Participants Destiny Hance – Ladenburg Thalmann Ramakanth Swayampakula – H.C. Wainwright Nick Sherwood – Maxim Group, LLC Walter Schenker – MAZ Partners Operator Greetings, and welcome to the electroCore Third Quarter 2023 Earnings Conference Call.
electroCore to Announce Third Quarter Financial Results on Wednesday, November 8
ROCKAWAY, N.J., Oct. 09, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial results for the third quarter ended September 30, 2023, after the close of the market on Wednesday, November 8, 2023. Management will host a conference call and webcast at 4:30 PM EST to discuss the financial results and answer questions.
electroCore to Participate in the Lytham Partners Fall 2023 Virtual Investor Conference
ROCKAWAY, N.J., Oct. 05, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger, will be participating in the Lytham Partners Fall 2023 Investor Conference taking place virtually on Tuesday, October 17, 2023.
electroCore to Present at iAccess Alpha's – Top 10 Best Ideas from the Buyside Virtual Conference
ROCKAWAY, N.J., Sept. 21, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger, will present at iAccess Alpha's – Top 10 Best Ideas from the Buyside Virtual Conference. Mr. Goldberger will also be available for one-on-one meetings held throughout the conference on September 26 and 27, 2023.
electroCore, Inc. (ECOR) Q2 2023 Earnings Call Transcript
electroCore, Inc. (NASDAQ:ECOR ) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ET Company Participants Daniel Goldberger - CEO & Director Brian Posner - CFO & Corporate Secretary Conference Call Participants John Vandermosten - Zacks Swayampakula Ramakanth - H.C. Wainwright & Co. Nick Sherwood - Maxim Tyler Bussian - Brookline Capital Markets Operator Greetings, and welcome to the electroCore Second Quarter 2023 Earnings Conference Call.
electroCore, Inc. (ECOR) Q1 2023 Earnings Call Transcript
electroCore, Inc. (NASDAQ:ECOR ) Q1 2023 Earnings Conference Call May 3, 2023 4:30 PM ET Company Participants Nicole Jones - IR Dan Goldberger - Chief Executive Officer Brian Posner - Chief Financial Officer Conference Call Participants John Vandermosten - Zacks Small-Cap Research Ramakanth Swayampakula - H.C. Wainwright Kemp Dolliver - Brookline Capital Markets Nick Sherwood - Maxim Group Operator And welcome to the electroCore First Quarter 2023 Earnings Call.
electroCore to Participate at Annual Aegis Virtual Conference
ROCKAWAY, N.J., May 01, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR) a commercial-stage bioelectronic medicine and wellness company, today announced that electroCore's Chief Executive Officer, Dan Goldberger, will present at the Annual Aegis Virtual Conference being held May 2-4, 2023.
ECOR Financial details
ECOR Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.22 | 1.34 | 1.38 | 1.82 | 2.91 | |
Net income per share | -23.05 | -9.04 | -4.37 | -4.69 | -3.42 | |
Operating cash flow per share | -23.01 | -7.73 | -3.46 | -3.52 | -2.66 | |
Free cash flow per share | -23.04 | -7.73 | -3.46 | -3.52 | -2.7 | |
Cash per share | 12.28 | 8.7 | 8.8 | 3.75 | 1.92 | |
Book value per share | 12.71 | 9.09 | 9.29 | 3.61 | 1.35 | |
Tangible book value per share | 12.48 | 8.79 | 9.29 | 3.45 | 1.35 | |
Share holders equity per share | 12.71 | 9.09 | 9.29 | 3.61 | 1.35 | |
Interest debt per share | 1.03 | 1.15 | 0.19 | 0.21 | 0.11 | |
Market cap | 46.71M | 60.84M | 34.46M | 18.25M | 32.81M | |
Enterprise value | 35.17M | 59.59M | 534.03K | 1.24M | 22.86M | |
P/E ratio | -1.03 | -2.59 | -2 | -0.82 | -1.74 | |
Price to sales ratio | 19.55 | 17.4 | 6.32 | 2.12 | 2.05 | |
POCF ratio | -1.04 | -3.03 | -2.53 | -1.1 | -2.24 | |
PFCF ratio | -1.03 | -3.03 | -2.53 | -1.1 | -2.21 | |
P/B Ratio | 1.88 | 2.57 | 0.94 | 1.07 | 4.41 | |
PTB ratio | 1.88 | 2.57 | 0.94 | 1.07 | 4.41 | |
EV to sales | 14.71 | 17.05 | 0.1 | 0.14 | 1.43 | |
Enterprise value over EBITDA | -0.84 | -2.5 | -0.02 | -0.05 | -1.3 | |
EV to operating cash flow | -0.78 | -2.96 | -0.04 | -0.07 | -1.56 | |
EV to free cash flow | -0.78 | -2.96 | -0.04 | -0.07 | -1.54 | |
Earnings yield | -0.97 | -0.39 | -0.5 | -1.21 | -0.57 | |
Free cash flow yield | -0.97 | -0.33 | -0.4 | -0.91 | -0.45 | |
Debt to equity | 0.08 | 0.13 | 0.02 | 0.04 | 0.08 | |
Debt to assets | 0.06 | 0.09 | 0.02 | 0.03 | 0.04 | |
Net debt to EBITDA | 0.27 | 0.05 | 1.54 | 0.74 | 0.57 | |
Current ratio | 2.9 | 3.84 | 6.84 | 3.01 | 1.76 | |
Interest coverage | 0 | -2.91K | 0 | -79.7 | 0 | |
Income quality | 1 | 0.86 | 0.79 | 0.75 | 0.78 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 4.14 | 1.2 | 0.47 | 0.64 | 0.33 | |
Intangibles to total assets | 0.03 | 0.03 | 0 | 0.03 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0.01 | |
Capex to revenue | -0.03 | 0 | 0 | 0 | -0.01 | |
Capex to depreciation | -0.28 | 0 | 0 | 0 | -0.16 | |
Stock based compensation to revenue | 1.63 | 0.93 | 0.61 | 0.31 | 0.11 | |
Graham number | 81.19 | 43.02 | 30.22 | 19.52 | 10.18 | |
ROIC | -1.53 | -0.82 | -0.5 | -1.21 | -2.16 | |
Return on tangible assets | -1.29 | -0.77 | -0.4 | -0.92 | -1.15 | |
Graham Net | 7.31 | 5.91 | 7.48 | 2.4 | 0.59 | |
Working capital | 17.39M | 16.74M | 32.06M | 14.13M | 6.17M | |
Tangible asset value | 24.45M | 22.85M | 36.65M | 16.31M | 7.44M | |
Net current asset value | 15.97M | 14.75M | 31.36M | 13.5M | 5.35M | |
Invested capital | 0.08 | 0.13 | 0.02 | 0.04 | 0.08 | |
Average receivables | 381.87K | 383.34K | 354.39K | 419.62K | 559K | |
Average payables | 3.95M | 3.64M | 1.81M | 1.84M | 2.15M | |
Average inventory | 1.42M | 866.3K | 1.1M | 1.67M | 2.07M | |
Days sales outstanding | 75.77 | 28.25 | 29.34 | 17.04 | 16.33 | |
Days payables outstanding | 1.64K | 436.68 | 406.65 | 480.87 | 281.56 | |
Days of inventory on hand | 281.08 | 176.8 | 358.57 | 447.67 | 281.17 | |
Receivables turnover | 4.82 | 12.92 | 12.44 | 21.43 | 22.36 | |
Payables turnover | 0.22 | 0.84 | 0.9 | 0.76 | 1.3 | |
Inventory turnover | 1.3 | 2.06 | 1.02 | 0.82 | 1.3 | |
ROE | -1.81 | -0.99 | -0.47 | -1.3 | -2.53 | |
Capex per share | -0.04 | 0 | 0 | 0 | -0.04 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.54 | 0.59 | 0.75 | 0.76 | 0.78 | |
Net income per share | -1.22 | -1.24 | -1.03 | -0.68 | -0.61 | |
Operating cash flow per share | -0.85 | -1.24 | -0.7 | -0.4 | -0.47 | |
Free cash flow per share | -0.85 | -1.24 | -0.72 | -0.41 | -0.48 | |
Cash per share | 3.74 | 2.51 | 1.78 | 2.27 | 1.6 | |
Book value per share | 3.6 | 2.5 | 1.49 | 1.86 | 1.12 | |
Tangible book value per share | 3.44 | 2.5 | 1.49 | 1.86 | 1.12 | |
Share holders equity per share | 3.6 | 2.5 | 1.49 | 1.86 | 1.12 | |
Interest debt per share | 0.18 | 0.12 | 0.14 | 0.11 | 0.09 | |
Market cap | 18.3M | 26.09M | 23.28M | 35.99M | 39.37M | |
Enterprise value | 1.29M | 14.86M | 15.5M | 23.18M | 29.41M | |
P/E ratio | -0.79 | -1.11 | -1.19 | -2.23 | -2.44 | |
Price to sales ratio | 7.15 | 9.38 | 6.56 | 7.98 | 7.58 | |
POCF ratio | -4.56 | -4.45 | -7.03 | -15.17 | -12.6 | |
PFCF ratio | -4.56 | -4.45 | -6.84 | -14.71 | -12.44 | |
P/B Ratio | 1.07 | 2.2 | 3.3 | 3.26 | 5.29 | |
PTB ratio | 1.07 | 2.2 | 3.3 | 3.26 | 5.29 | |
EV to sales | 0.5 | 5.35 | 4.37 | 5.14 | 5.67 | |
Enterprise value over EBITDA | -0.22 | -2.45 | -3.32 | -6.04 | -8.5 | |
EV to operating cash flow | -0.32 | -2.54 | -4.68 | -9.77 | -9.42 | |
EV to free cash flow | -0.32 | -2.54 | -4.56 | -9.47 | -9.3 | |
Earnings yield | -0.32 | -0.22 | -0.21 | -0.11 | -0.1 | |
Free cash flow yield | -0.22 | -0.22 | -0.15 | -0.07 | -0.08 | |
Debt to equity | 0.04 | 0.06 | 0.09 | 0.06 | 0.08 | |
Debt to assets | 0.03 | 0.04 | 0.05 | 0.03 | 0.04 | |
Net debt to EBITDA | 2.88 | 1.85 | 1.67 | 3.34 | 2.88 | |
Current ratio | 3.01 | 2.63 | 1.73 | 2.1 | 1.76 | |
Interest coverage | -41.67 | 52.08 | 0 | 0 | 0 | |
Income quality | 0.69 | 1 | 0.68 | 0.59 | 0.77 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 1.91 | 0 | 0 | |
Research and developement to revenue | 0.64 | 0.65 | 0.33 | 0.28 | 0.21 | |
Intangibles to total assets | 0.03 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0.03 | 0.03 | 0.01 | |
Capex to revenue | 0 | 0 | -0.03 | -0.02 | -0.01 | |
Capex to depreciation | 0 | 0 | -0.28 | -0.25 | -0.09 | |
Stock based compensation to revenue | 0.23 | 0.21 | 0.05 | 0.12 | 0.08 | |
Graham number | 9.95 | 8.34 | 5.88 | 5.34 | 3.93 | |
ROIC | -0.32 | -0.45 | -0.59 | -0.33 | -0.46 | |
Return on tangible assets | -0.24 | -0.32 | -0.34 | -0.2 | -0.25 | |
Graham Net | 2.39 | 1.45 | 0.56 | 1.03 | 0.49 | |
Working capital | 14.13M | 9.53M | 4.83M | 9.33M | 6.17M | |
Tangible asset value | 16.31M | 11.85M | 7.06M | 11.04M | 7.44M | |
Net current asset value | 13.5M | 8.92M | 4.25M | 8.77M | 5.35M | |
Invested capital | 0.04 | 0.06 | 0.09 | 0.06 | 0.08 | |
Average receivables | 382.5K | 307K | 225.5K | 413.5K | 653K | |
Average payables | 2.02M | 2.07M | 2.14M | 2.66M | 2.6M | |
Average inventory | 1.98M | 2.23M | 2.42M | 2.43M | 2.33M | |
Days sales outstanding | 14.1 | 6.9 | 6.03 | 11.76 | 12.43 | |
Days payables outstanding | 299.39 | 393.21 | 351.38 | 412.97 | 176.97 | |
Days of inventory on hand | 278.72 | 486.94 | 364.31 | 339.71 | 176.73 | |
Receivables turnover | 6.38 | 13.05 | 14.92 | 7.65 | 7.24 | |
Payables turnover | 0.3 | 0.23 | 0.26 | 0.22 | 0.51 | |
Inventory turnover | 0.32 | 0.18 | 0.25 | 0.26 | 0.51 | |
ROE | -0.34 | -0.5 | -0.69 | -0.37 | -0.54 | |
Capex per share | 0 | 0 | -0.02 | -0.01 | -0.01 |
ECOR Frequently Asked Questions
What is electroCore, Inc. stock symbol ?
electroCore, Inc. is a US stock , located in Rockaway of Nj and trading under the symbol ECOR
What is electroCore, Inc. stock quote today ?
electroCore, Inc. stock price is $6.1 today.
Is electroCore, Inc. stock public?
Yes, electroCore, Inc. is a publicly traded company.